IL6 and liver disorder: In another study of ours, which analyzed a broad profile of serum adipokines and cytokines in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) (assessed by elastography and other diagnostic criteria), IL-6 was identified as the strongest predictor of this disease, regardless of gender [35], a finding that is also supported by other researchers [36].